• Wal-Mart’s incredible week
    Posted by on October 13th, 2017 at 4:17 pm

  • CWS Market Review – October 13, 2017
    Posted by on October 13th, 2017 at 7:08 am

    “In business, competition is never as healthy as total domination.” – Peter Lynch

    This Thursday will mark the 30th anniversary of the 1987 stock market crash, or “Meltdown Monday” as it’s come to be known. On October 19, 1987, the Dow plunged 508 points. In percentage terms, this was a loss of 22.61%. In today’s terms, that would be like a loss of more than 5,000 points!

    Three decades later, the 1987 crash still ranks as the biggest one-day percentage loss in history. It’s nearly double the second-biggest loss, which came in October 1929. With the modern “circuit breakers,” this record may never be broken. If the S&P 500 falls by 20% nowadays, the exchanges shut down for the day.

    I often hear stock market “experts” predicting that another 1987 is about to come our way. I always think to myself, “oh, so you’re predicting another 1,000% return over the next 30 years.” Yes, that’s what the Wilshire 5000 did measuring from the market close on the day of the crash. And if we include dividends, then the index is up more than 2,000%. The fact is that the 1987 panic was a great time to buy.

    That’s an interesting lesson to ponder as we start the third-quarter earnings season. Over the next few weeks, a large majority of our Buy List stocks will tell us how business was during the summer. I’m expecting good results for our stocks. In this week’s CWS Market Review, I’ll highlight our first earnings reports coming next week. I’ll also bring you up to speed on the latest news on our Buy List stocks. Later on, I’ll share with you some names I’m considering for next year’s Buy List.

    Three Buy List Earnings Reports Next Week

    There’s an interesting twist to this earnings season. Companies that generate most of their revenue from outside the U.S. are expected to see earnings growth of 7.9%. Yet firms that get most of their revenue inside the U.S. are expected to see earnings fall by 0.1%.

    The big winner of this earnings season is expected to be the energy sector, but that’s really because the comparisons with a year ago were so poor. The market is quietly changing before our eyes. For example, intra-market correlations are the lowest they’ve been since the financial crisis. In simpler terms, the different market sectors have lately been doing their own thing. Normally, they tend to move together. This probably means that investors are willing to shoulder more risk.

    Another example of this can be seen in the junk bond market. It’s amazing how much things have changed since the financial crisis. Earlier this week, junk bond yields in Europe dropped to 2.29%. That’s an all-time low. Eight years ago, junk bonds in Europe were yielding close to 26%.

    Here in America, a Federal Reserve interest rate hike in December now seems like a certainty. The release this week of the minutes from the Fed’s last meeting showed that the central bank is dedicated to raising rates. Still, the Fed members seem puzzled why inflation is still so low.

    Now let’s take a look at an earnings calendar for the third quarter. Let me caution that I haven’t heard back from all the companies about when they’ll report. (Some companies are better at this than others.) I’ve also listed Wall Street’s consensus for each stock. Bear in mind, these can change.

    Company Ticker Date Estimate
    Alliance Data Systems ADS 19-Oct $5.02
    Danaher DHR 19-Oct $0.95
    Snap-On SNA 19-Oct $2.43
    Sherwin-Williams SHW 24-Oct $4.70
    Wabtec WAB 24-Oct $0.84
    Aflac AFL 25-Oct $1.63
    Express Scripts ESRX 25-Oct $1.90
    Axalta Coating Systems AXTA 26-Oct $0.32
    Cerner CERN 26-Oct $0.62
    Microsoft MSFT 26-Oct $0.72
    Stryker SYK 26-Oct $1.50
    Fiserv FISV 31-Oct $1.30
    Cognizant Technology Sol CTSH 1-Nov $0.95
    Ingredion INGR 1-Nov $2.02
    Becton, Dickinson BDX 2-Nov $2.37
    Intercontinental Exchange ICE 2-Nov $0.70
    Moody’s MCO 3-Nov $1.37
    CR Bard BCR NA $2.94
    Cinemark CNK TBA $0.35
    Continental Building Products CBPX TBA $0.30
    Signature Bank SBNY TBA $2.20

    I’ve included Becton, Dickinson on the earnings calendar since the CR Bard acquisition will be completed this quarter.

    We have three earnings reports next Thursday. Leading off will be Danaher (DHR), the diversified manufacturer. DHR’s last report was just fine in my eyes, but the shares took a dive. A few days later, DHR made a U-turn and rallied to a new high. Once again, there’s a lesson in a little patience.

    Danaher told us to expect Q3 earnings to range between 92 and 96 cents per share. That was a tad light, but it’s nothing to be concerned about. In July, the company raised its full-year guidance range to $3.85 to $3.95 per share. There’s a decent chance they’ll revise that higher next week. Danaher is an 11.8% winner YTD for us.

    Alliance Data Systems (ADS) has not been the easiest stock to own. Shares of the loyalty-rewards stock were crushed in 2016, and they started to recover. That is, until this past summer. In July, ADS reported better-than-expected Q2 earnings, but the company lowered its full-year guidance by 40 cents to $18.10 per share. The company said their brand-loyalty business “produced soft results.” At the same time, ADS increased its revenue guidance from $7.7 billion to $7.8 billion.

    ADS also said it’s “comfortable” in giving initial 2018 guidance of $21.50 per share in core earnings. The consensus on Wall Street was for earnings of $21.42 per share. Still, that wasn’t enough to appease the market gods. ADS dropped nearly 10% after the Q2 report. For Q3, Wall Street expects earnings of $5.02 per share. I think we’ll see that ADS is back on track.

    Snap-on (SNA) was another one of our stocks that got dinged after reporting better-than-expected results. The CEO mentioned “headwinds” in their tool group. The good news is that the shares seem to have found a base two months ago, and the stock has been creeping higher lately. I’m looking for more good results. The consensus on Wall Street is for Q3 earnings of $2.43 per share.

    Let me also add a quick word on Signature Bank (SBNY). The bank hasn’t said yet when they’ll report Q3 earnings. However, going by previous quarters, I assume it will be close to the 19th, so I’ll include it here. I also want to highlight SBNY because the stock is a very good bargain at the moment.

    In July, SBNY met Wall Street’s earnings expectations of $2.21 per share. However, that excluded the bank’s write-down for the bath they took on their medallion loans. Frankly, they got creamed in that business. Outside that, Signature’s business is moving along. For Q2, their net interest margin was 3.11%. That’s pretty good.

    The shares have drifted from $150 in June to below $125 recently. It’s very reasonable for Signature to earn $10 per share this year. I’m sticking with SBNY.

    Some Candidates for Next Year’s Buy List

    The rules of the Buy List stipulate that all 25 stocks are held for the entire calendar year. I can’t make any changes until the end of the year. However, I’ve been looking at some candidates for possible inclusion on the 2018 Buy List. I wanted to share some of these names with you.

    Let me make it clear that this is by no means a guarantee that a stock listed here will be on next year’s Buy List. I still have two months to finalize my decisions, but I wanted you to know what I’m looking at.

    Church & Dwight (CHD)
    Check Point Software (CHKP)
    Colgate-Palmolive (CL)
    Torchmark (TMK)
    FactSet Research (FDS)
    Kellogg (K)
    Atrion (ATRI)
    ADP (ADP)
    Clorox (CLX)
    Broadridge Financial Solutions (BR)
    Mesa Labs (MLAB)

    If you’ve been with us for a long time, these stocks ought to resemble for you the kinds of stocks we normally favor (strong businesses, solid financials). My plan was to give you seven names, and I just listed 11. That tells you how difficult it is for me to narrow down my selections.

    Making changes once a year is tough, but it’s probably for the best.

    Buy List Updates

    Here are some brief updates on some of our Buy List stocks.

    Express Scripts (ESRX) said they’re buying EviCore Healthcare for $3.6 billion. ESRX reports again on October 25.

    Cinemark (CNK) dropped this week after reports that the new Blade Runner isn’t such a hit at the box office. The selling hit all the movie chains.

    On Monday, Axalta Coating Systems (AXTA) updated its Q3 guidance in light of the hurricanes. The company now sees Q3 and full-year EBITDA in the range of $205-$215 million and $870-$900 million, respectively. Sales for Q3 should be between $1.08-$1.10 billion while full-year sales are to expected to grow between 6% and 7%. The stock dropped 3.8% on Monday. Earnings are due out on October 26.

    Barron’s ran a nice feature on Cognizant Technology Solutions (CTSH). They noted that the firm is making inroads in digital consulting.

    That’s all for now. Next week will be dominated by earnings reports, but there will be some key economic reports as well. On Tuesday, the industrial production report comes out. Then on Wednesday, the housing starts report comes out as well as the Beige Book. On Friday, Janet Yellen will be speaking, plus the existing homes report comes out. Be sure to keep checking the blog for daily updates. I’ll have more market analysis for you in the next issue of CWS Market Review!

    – Eddy

  • Morning News: October 13, 2017
    Posted by on October 13th, 2017 at 7:03 am

    Global Demand for Bitcoin Shifts Wildly in Response to Regulation

    Japan Inc. Scandals Build a Case for Corporate Reform

    U.S. Corporate Tax Shake-Up Could Fuel Tension With Allies

    Curtain Falls on a Great Tech Rivalry

    Equifax Takes Down Webpage After Report Of New Cybersecurity ‘Situation’

    JPMorgan And Citi: 2 Peas In A Pod

    Richard Branson’s Virgin and Hyperloop One Transit Pods Become Fast Friends

    AT&T: This Is the Real Storm Crushing the Stock

    Google Unveils Job Training Initiative With $1 Billion Pledge

    Amazon Is Making It Easier For Teens to Use Their Parents’ Credit Cards

    Uber Launches Appeal Against London License Ban

    Tech Giants, Once Seen as Saviors, Are Now Viewed as Threats

    Jeff Carter: The Director

    Ben Carlson: Bond Market Bubbles Are Not What You Think

    Howard Lindzon: Bitcoin…FOMO or Foist

    Be sure to follow me on Twitter.

  • My Watch List
    Posted by on October 12th, 2017 at 1:06 pm

    Here’s my latest Watch List. This is my unofficial list of high-quality stocks I like to follow. If a stock is on this list, then there’s a very good chance that it’s in the upper 5% of well-run companies on Wall Street. This is the elite.

    I’m often asked how I go about selecting the stocks for my Buy List. It’s actually very simple. I have this Watch List of stocks and if one of them falls down to a very attractive price, then it becomes a contender for the new Buy List. I like to think of the Watch List as the minor leagues for the Buy List. Strong prospects earn their way up the ladder.

    The Watch List is very informal. Unlike the Buy List, I’m constantly adding and deleting names. In fact, I have a bad habit of letting the Watch List grow too large. I often find myself adding three names for every one I delete. Ideally, I like to keep the Watch List below 100 names.

    Company Ticker
    AbbVie Inc. ABBV
    AmerisourceBergen ABC
    Abbott Laboratories ABT
    Aceto Corporation ACET
    Automatic Data Processing ADP
    AMETEK, Inc. AME
    Affiliated Managers Group AMG
    American Tower AMT
    Ansys, Inc. ANSS
    Anthem, Inc. ANTM
    Amphenol Corporation APH
    Atrion Corporation ATRI
    AutoZone, Inc. AZO
    Balchem Corporation BCPC
    Becton, Dickinson BDX
    Brown-Forman BF-B
    Biogen Inc. BIIB
    Broadridge Financial Solutions BR
    Church & Dwight CHD
    Check Point Software CHKP
    Colgate-Palmolive Company CL
    The Clorox Company CLX
    The Cooper Companies, Inc. COO
    Costco COST
    Copart, Inc. CPRT
    Cintas Corporation CTAS
    CVS Health Corporation CVS
    Ecolab Inc. ECL
    Eagle Bancorp, Inc. EGBN
    Edwards Lifesciences EW
    Exponent, Inc. EXPO
    Fastenal Company FAST
    FactSet Research Systems FDS
    F5 Networks, Inc. FFIV
    Fortive Corporation FTV
    General Mills, Inc. GIS
    Gentex Corporation GNTX
    Global Payments Inc. GPN
    Hilton Grand Vacations Inc. HGV
    Hingham Institution for Savings HIFS
    Henry Schein, Inc. HSIC
    The Hershey Company HSY
    IDEXX Laboratories, Inc. IDXX
    IDEX Corporation IEX
    International Flavors & Fragrances IFF
    Intuit Inc. INTU
    Intuitive Surgical, Inc. ISRG
    Gartner, Inc. IT
    J.B. Hunt Transport Services JBHT
    J&J Snack Foods Corp. JJSF
    Jack Henry & Associates, Inc. JKHY
    Johnson & Johnson JNJ
    Kellogg Company K
    Kimberly-Clark Corporation KMB
    Medtronic plc MDT
    The Middleby Corporation MIDD
    McCormick & Company MKC
    Mesa Laboratories, Inc. MLAB
    3M Company MMM
    Mettler-Toledo International MTD
    Mylan N.V. MYL
    Neogen Corporation NEOG
    NIKE, Inc. NKE
    Old Dominion Freight Line ODFL
    O’Reilly Automotive, Inc. ORLY
    Paychex, Inc. PAYX
    Prosperity Bancshares, Inc. PB
    The Priceline Group Inc. PCLN
    Procter & Gamble PG
    PayPal Holdings, Inc. PYPL
    Papa John’s International PZZA
    ResMed Inc. RMD
    Rollins, Inc. ROL
    Roper Technologies, Inc. ROP
    Starbucks Corporation SBUX
    SEI Investments Co. SEIC
    Silgan Holdings Inc. SLGN
    S&P Global Inc. SPGI
    Stericycle, Inc. SRCL
    TransDigm Group TDG
    The TJX Companies, Inc. TJX
    Torchmark Corporation TMK
    Thermo Fisher Scientific TMO
    Tractor Supply Company TSCO
    The Toro Company TTC
    Texas Roadhouse, Inc. TXRH
    Tyler Technologies, Inc. TYL
    Universal Health Services UHS
    UnitedHealth Group UNH
    Visa Inc. V
    Verisk Analytics, Inc. VRSK
    VeriSign, Inc. VRSN
    Waters Corporation WAT
    Walgreens Boots Alliance WBA
    WD-40 Company WDFC
    Winmark Corporation WINA
    Waste Management WM
    Wolverine World Wide WWW
    Zimmer Biomet Holdings ZBH
  • Morning News: October 12, 2017
    Posted by on October 12th, 2017 at 7:11 am

    Bitcoin Just Smashed Through the $5,000 Barrier Again. Here’s Why

    The New Rules That Could Make ETFs Unstoppable

    Barnier Says ‘Deadlock’ Reached as Brexit Cliff Inches Closer

    Beijing’s Closer Embrace is Bad News for Big Tech

    Paris Plans to Banish All But Electric Cars By 2030

    Facebook Pushes Ad Overhaul Before 2018 U.S. Election

    HSBC Names Insider John Flint CEO as Tucker Bows to Tradition

    Will the ‘Southwest Effect’ Lower the Cost of Hawaiian Flights?

    Qualcomm Fined Record $773 Million in Taiwan Antitrust Probe

    Kobe Steel Problems May Be More Widespread, Raising Fears on High-Speed Rail

    Coach Changes Corporate Name To Tapestry, Brand Name Is Unchanged

    Italy’s Gucci Bans Fur, Joining Others in Seeking Alternatives

    Roger Nusbaum: Why Does FINRA Have An Investment Portfolio?

    Cullen Roche: The Future of Active Management

    Jeff Miller: What Investors (and Their Advisors) Can Learn from Monty Hall

    Be sure to follow me on Twitter.

  • Morning News: October 11, 2017
    Posted by on October 11th, 2017 at 7:06 am

    IMF Warns Against Complacency Even as Global Growth Gains Steam

    Japan Shares Rise With Nikkei 225 Closing at Highest Since 1996

    Japan’s Quality Control Is Out of Control

    Why Chicago’s Soda Tax Fizzled After Two Months — And What It Means for the Anti-Soda Movement

    Alibaba’s Meek Big Splash

    P&G May Have Beaten Peltz, But Shouldn’t Spike the Ball

    Apple Joins Forces With Steven Spielberg’s Amblin Television

    Amazon’s Clever Solution to Stolen Deliveries: Your Trunk

    Walmart Announces Speedy Returns Program

    Hyundai Mounts Charm Offensive at U.S. Dealers to Stem Slump

    Asset Manager BlackRock’s Profit Beats Wall Street View as Fees Rise

    Joshua Brown: Where Have All The Cowboys Gone?

    Cullen Roche: Congratulations Richard Thaler!

    Michael Batnick: The Price of Progress

    Jeff Carter: Where Disagreement is Embraced

    Be sure to follow me on Twitter.

  • Dow to 1,000,000 in 100 Years?
    Posted by on October 10th, 2017 at 2:22 pm

    Warren Buffett recently said that the Dow Jones Industrial Average will get to 1,000,000 in 100 years. To be fair, he said “over” 1,000,000.

    That may sound incredible, but he was actually being conservative. Let’s get mathy.

    Yesterday, the Dow closed at 22,761.07. To get to 1,000,000 it will need to grow by 3.855% per year for the next 100 years.

    Contrast that to the last 100 years. The Dow closed at 79.26 on October 9, 1917. That works out to CAGR of 5.823%. So Buffett was assuming a growth rate of one-third less than before.

    If we’re able to maintain the same rate of growth as the last century, then we’ll hit 1,000,000 in no time.

    Just 2084.

  • Express Scripts Buys EviCore Healthcare
    Posted by on October 10th, 2017 at 2:16 pm

    Express Scripts (ESRX) said they’re buying EviCore Healthcare for $3.6 billion.

    Buying EviCore will help Express Scripts broaden its reach beyond prescription drugs into being a gatekeeper for insurance companies for a wider range of medical services. Health plans hire EviCore, which manages medical benefits for 100 million people, to help reduce medically unnecessary imaging and other expensive tests.

    The purchase will complement Express Scripts’ main business of managing prescription-drug benefits for health plans, employers and unions. The combination provides “significant opportunities for cross-selling to both client bases,” Express Scripts said in a statement.

    Express Scripts said that the deal, which must be approved by regulators, is expected to close in the fourth quarter of 2017. EviCore will be run as a standalone business unit within Express Scripts, the company said.

    Express Scripts is down about 1.8% today.

  • Stock Returns and TIPs Yields
    Posted by on October 10th, 2017 at 9:40 am

    I recently looked at the relationship between stock market returns and TIPs yields. I found that 1.10% on the five-year TIP is a good tipping point for the stock market.

    When the five-year TIP has been yielding 1.1% or more, the stock market (as measured by the Wilshire 5000 Total Return) has lost 2.1% annualized.

    But when the five-year TIP has been 1.09% or less, then the market has gained 17.1% annualized.

    The data goes back to January 2003 so we almost have 15 years of data. I wish we had more. I suspect that over time, we’ll see a tipping point yield around 1% to 1.5%.

    On Friday, the five-year TIP closed at 0.19%. So going by that, we’re still a long way from bonds being competitive against stocks.

    Here’s the five-year TIPs yield along with its tipping yield in red. The blue line hasn’t been above the red line in over eight years.

  • The Stock Market Bottomed Out 15 Years Ago Today
    Posted by on October 10th, 2017 at 9:13 am

    The S&P 500 reached its intraday low exactly 15 years ago today. At 10:10 am on 10/10/2002, the S&P 500 got down to 768.63.

    Later that day, the market would rally to close over 800 so the lowest close came the previous day on October 9 when the S&P 500 closed at 776.76. Weirdly, that number is very close to the Dow’s lowest number during the bear market that ended 20 years before (776.92).

    The bull market would last exactly five years. Or almost exactly. The highest close would come on October 9, 2007 at 1,565.15. The intra-day high (1576.09) came on October 11. Those days perfectly bookend the fifth birthday of the rally.

    Basically, the stock market doubled in five years.